Key result
Prosthetic valve endocarditis is a life-threatening disease with increasing incidence in transcatheter-implanted valves, requiring multidisciplinary management and updated diagnostic criteria.
Answers are grounded in this paper and cite their sources.
May reduce complications with prompt targeted therapy in prosthetic valve endocarditis; leaves open optimal regimens for confirmation.
During the past 6 decades, there have been numerous changes in prosthetic valve endocarditis (PVE), currently affecting an older population and increasing in incidence in patients with transcatheter-implanted valves. Significant microbiologic (molecular biology) and imaging diagnostic (fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography) advances have been incorporated into the 2023 Duke-International Society for Cardiovascular Infectious Diseases infective endocarditis diagnostic criteria, thus increasing the diagnostic sensitivity for PVE without sacrificing specificity in validation studies. PVE is a life-threatening disease requiring management by multidisciplinary endocarditis teams in cardiac centers to improve outcomes. Novel surgical options are now available, and an increasing set of patients may avoid surgical intervention despite indication. Selected patients may complete parenteral or oral antimicrobial treatment at home. Finally, patients with prosthetic valves implanted surgically or by the transcatheter approach are candidates for antibiotic prophylaxis before invasive dental procedures.
No takes yet. Share an insight, caveat, or question.
Cuervo et al. (2024) conducted a review in Prosthetic valve endocarditis. Prosthetic valve endocarditis is a life-threatening disease with increasing incidence in transcatheter-implanted valves, requiring multidisciplinary management and updated diagnostic criteria.
Synapse has enriched 10 related papers. Consider them for comparative context: